Effect of antiarrhythmic and diuretic agents on phagocytosis and bacterial killing by human neutrophilic leukocytes.
D000433:1-Propanol / Q000494:pharmacology; D000526:Alprenolol / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology; D000889:Anti-Arrhythmia Agents / Q000097:blood / Q000494:pharmacology*; D001770:Blood Bactericidal Activity / Q000187:drug effects*; D002463:Cell Membrane Permeability; D003470:Culture Media; D004232:Diuretics / Q000097:blood / Q000494:pharmacology*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008012:Lidocaine / Q000494:pharmacology; D009504:Neutrophils / Q000187:drug effects*; D010042:Ouabain / Q000494:pharmacology; D010587:Phagocytosis / Q000187:drug effects*; D010672:Phenytoin / Q000494:pharmacology; D013210:Staphylococcus / Q000187:drug effects; D013268:Stimulation, Chemical; D013997:Time Factors
D000605:Amino Alcohols; D000889:Anti-Arrhythmia Agents; D003470:Culture Media; D004232:Diuretics; D010042:Ouabain; D010672:Phenytoin; D000526:Alprenolol; D000433:1-Propanol; D008012:Lidocaine